Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Guokeyigong Science and Technology Development is a specialized industrialization platform dedicated to the translation of advanced medical device research into market-ready products. Affiliated with the Suzhou Institute of Biomedical Engineering and Technology (SIBET) of the Chinese Academy of Sciences, the company serves as a critical link between academic innovation and the healthcare industry. Its primary focus areas include high-end medical imaging, in vitro diagnostics, and rehabilitation equipment. The company provides a comprehensive suite of services, including engineering prototyping, clinical trial coordination, and regulatory registration support. By leveraging the scientific resources of the Chinese Academy of Sciences, it fosters a robust ecosystem for medical technology startups in the Tianjin region. Guokeyigong's mission is to reduce the time and cost associated with medical device development while ensuring high standards of quality and clinical efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Guokeyigong Science and Technology Development.